中国癌症杂志 ›› 2020, Vol. 30 ›› Issue (5): 394-400.doi: 10.19401/j.cnki.1007-3639.2020.05.012

• 综述 • 上一篇    

乳腺癌异质性的研究进展及临床意义

蒋梦怡 1 ,陆言巧 2 ,王红霞 1   

  1. 1. 南京医科大学附属上海一院临床医学院肿瘤科,上海 200080 ;
    2. 上海交通大学附属胸科医院心内科,上海 200030
  • 出版日期:2020-05-30 发布日期:2020-06-09
  • 通信作者: 王红霞 E-mail: whx365@126.com

Research progress and clinical significance of breast cancer heterogeneity

JIANG Mengyi 1 , LU Yanqiao 2 , WANG Hongxia 1   

  1. 1. Department of Oncology, Shanghai General Hospital of Nanjing Medical University, Shanghai 200080, China; 2. Department of Cardiovascular Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai 200030, China
  • Published:2020-05-30 Online:2020-06-09
  • Contact: WANG Hongxia E-mail: whx365@126.com

摘要: 异质性是乳腺癌的重要特征之一。尽管多数研究认为乳腺癌为单克隆起源,但由于发生、发展过程中多次分裂增殖、不断进化,表观遗传、基因组学及微环境改变导致细胞具有不同表型及生物学特征,从而产生异质性,表现为不同的组织学类型、分化程度、细胞增殖速率、侵袭转移能力及治疗反应性等诸多方面。乳腺癌个体化医疗的精准实施要求考虑到不同分子亚型以及同一个肿瘤组织内不同细胞亚群的存在。就乳腺癌异质性的起源、分类、表型特点及临床意义等研究进展进行综述。

关键词: 乳腺癌, 肿瘤异质性, 临床意义, 三阴性乳腺癌, 肿瘤微环境异质性

Abstract: Heterogeneity is one of the characteristics of breast cancer. Although most of the studies agree with the monoclonal origin of spontaneous tumor, due to multiple division and proliferation, epigenetic and genomic changes in the process of occurrence and development, cells present different phenotypes and biological characteristics. These differences are reflected in tissue type, differentiation degree, cell proliferation rate, invasion and metastasis abilities, therapeutic response and many other aspects. The precise implementation of individualized medical treatment must treat the different molecular types represented by different histology and molecular characteristics differently and consider the existence of different cell subsets in the same tumor tissue. This article reviewed the mechanism and research progress of breast cancer heterogeneity in order to facilitate the clinical development of breast cancer precision medicine.

Key words: Breast cancer, Tumor heterogeneity, Clinical significance, Triple-negative breast cancer, Heterogeneity of tumor microenvironment